跳至主要内容
临床试验/CTRI/2023/07/055239
CTRI/2023/07/055239尚未招募3 期

Evaluation of comparative efficacy of Hingwadi tail matrabasti versus Mefenamic acid in management of Kashtartava (primary spasmodic dysmenorrhea) - NI

Datta Meghe Institute of Medical Science0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients diagnosed as primary spasmodic dysmenorrhoea.
  • 2. Patients complaining painful menstruation for first two days for two Consecutive cycles.
  • 3. Patients having regular menstrual cycles.

排除标准

  • 1.Patients with major systemic diseases.
  • 2.Patients having congenital anomalies leading to dysmenorrhea.
  • 3.Patients having any detectable organic pelvic pathology.
  • 4.Patients on hormonal therapy

研究者

发起方
Datta Meghe Institute of Medical Science

相似试验